Jessica Meng brings to CareDx deep expertise in building successful commercial strategies for both established companies and entrepreneurial ventures in the pharmaceutical and molecular diagnostics industries. "CareDx is a critical part of the transplant ecosystem and the care of hundreds of thousands of patients. Transplant centers rely on the Company's testing services, SaaS software solutions, and laboratory products to improve health outcomes," said Meng. "I'm excited to be a part of the transplant community and work with its incredible clinician leaders on the next generation of CareDx solutions." As Chief Commercial Officer Jessica Meng will be responsible for driving CareDx's commercial growth globally across its portfolio. Meng previously served as Chief Commercial Officer at DELFI Diagnostics, and General Manager of Women's Health at Myovant Sciences. She previously held sales and marketing leadership roles at Veracyte and Genentech.